REG - Convatec Group PLC - Results of AGM

ConvaTecAnnouncement

Yesterday 16:30

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250522:nRSV8542Ja&default-theme=true

RNS Number : 8542J  Convatec Group PLC  22 May 2025

22 May 2025

Convatec Group Plc

("Convatec" or "the Company")

 

Results of the Annual General Meeting

 

 

Convatec's Annual General Meeting ("AGM") was held at FGS Global, The Adelphi,
1-11 John Adam Street, London WC2N 6HT on Thursday, 22 May 2025 at 14:00.

 

All resolutions set out in the Notice of Meeting were duly passed by way of a
poll.  The results are set out below:

 

                                                                                        For(1)                  Against(1)            Votes total               % of ISC voted(3)  Withheld(2)

(excluding withheld(2))
 Resolution                                                                             No of shares   %        No of shares  %
 1       To receive the Annual Report and Accounts 2024                                 1,859,153,095  100.00%  357           0.00%   1,859,153,452             90.70%             0.12%

 2       To approve the Directors' Remuneration Report                                  1,827,586,209  98.20%   33,510,408    1.80%   1,861,096,617             90.79%             0.02%

 3       To approve the New Remuneration Policy                                         1,225,892,782  67.04%   602,748,451   32.96%  1,828,641,233             89.21%             1.79%

 4       To declare Final Dividend                                                      1,861,239,025  100.00%  357           0.00%   1,861,239,382             90.80%             0.01%

 5       To re-elect Dr John McAdam as a Director                                       1,857,368,570  99.80%   3,799,586     0.20%   1,861,168,156             90.80%             0.01%

 6       To re-elect Karim Bitar as a Director                                          1,860,834,913  99.98%   393,354       0.02%   1,861,228,267             90.80%             0.01%

 7       To re-elect Jonny Mason as a Director                                          1,857,599,313  99.80%   3,632,298     0.20%   1,861,231,611             90.80%             0.01%

 8       To re-elect Margaret Ewing as a Director                                       1,860,699,389  99.98%   445,784       0.02%   1,861,145,173             90.80%             0.01%

 9       To re-elect Brian May as a Director                                            1,836,326,640  98.67%   24,818,533    1.33%   1,861,145,173             90.80%             0.01%

 10      To re-elect Professor Constantin Coussios as a Director                        1,857,806,020  99.82%   3,337,951     0.18%   1,861,143,971             90.80%             0.01%

 11      To re-elect Heather Mason as a Director                                        1,860,666,861  99.97%   469,206       0.03%   1,861,136,067             90.80%             0.01%

 12      To re-elect Kim Lody as a Director                                             1,857,805,175  99.82%   3,337,951     0.18%   1,861,143,126             90.80%             0.01%
 13      To re-elect Sharon O'Keefe as a Director                                       1,857,687,019  99.82%   3,431,921     0.18%   1,861,118,940             90.80%             0.01%

 14      To re-appoint Deloitte LLP as auditors                                         1,859,049,205  99.97%   474,329       0.03%   1,859,523,534             90.72%             0.10%

 15      To authorise the Audit and Risk Committee on behalf of the Board to agree the  1,861,086,418  99.99%   140,830       0.01%   1,861,227,248             90.80%             0.01%
         auditors' remuneration

 16      To approve the Convatec Group Omnibus Incentive Plan.                          1,383,218,387  75.64%   445,433,823   24.36%  1,828,652,210             89.21%             1.79%

 17      To authorise political donations and political expenditure                     1,826,036,560  98.11%   35,154,792    1.89%   1,861,191,352             90.80%             0.01%

 18      To authorise the Directors to allot shares                                     1,691,265,786  90.87%   169,902,975   9.13%   1,861,168,761             90.80%             0.01%

 19      To authorise the Directors to disapply pre-emption rights*                     1,727,143,179  92.80%   133,938,227   7.20%   1,861,081,406             90.79%             0.02%

 20      To authorise the Directors to disapply pre-emption rights in connection with   1,679,395,885  90.63%   173,609,702   9.37%   1,853,005,587             90.40%             0.45%

       an acquisition or specified capital investment*

 21      To authorise the Directors to make market purchases of own shares*             1,860,535,148  99.99%   132,334       0.01%   1,860,667,482             90.77%             0.04%

 22      To authorise the calling of a general meetings on 14 clear days' notice*       1,768,872,258  95.04%   92,347,152    4.96%   1,861,219,410             90.80%             0.01%

 

Notes to the disclosure:

*Special Resolution

1.    Votes "For" and "Against" are expressed as a percentage of votes
received.

2.    A "Vote withheld" is not a vote in law and is not counted in the
calculation of the votes "For" or "Against" a resolution.

3.    Total number of shares in issue is 2,049,789,559 (90.8% of capital
was voted).

 

Computershare acted as scrutineer of the poll on all resolutions.

 

We note support received for all resolutions today. We acknowledge that whilst
a majority of shareholders voted in favour of Resolution 3 (Directors'
Remuneration Policy) and Resolution 16 (Convatec Group Omnibus Incentive
Plan), the overall vote level for each was below 80%.  The Board engaged
extensively with shareholders throughout the development of our remuneration
proposals and is committed to ongoing engagement with investors. We will
provide an update within six months of today's meeting, consistent with the UK
Corporate Governance Code.

 

In accordance with UKLR 6.4.2, copies of the resolutions that do not
constitute ordinary business that were passed at the Annual General Meeting
have been submitted to the National Storage Mechanism and will be available
for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

Enquiries

 

James Kerton, Company Secretary

Tel: +44 (7827) 036059

Email: cosec@convatec.com (mailto:cosec@convatec.com)

 

Convatec Group Plc's LEI code is 213800LS272L4FIDOH92

 

About Convatec

 

Pioneering trusted medical solutions to improve the lives we touch: Convatec
is a global medical products and technologies company, focused on solutions
for the management of chronic conditions, with leading positions in Advanced
Wound Care, Ostomy Care, Continence Care, and Infusion Care. With more than
10,000 colleagues, we provide our products and services in around 90
countries, united by a promise to be forever caring. Our solutions provide a
range of benefits, from infection prevention and protection of at-risk skin,
to improved patient outcomes and reduced care costs. Convatec's revenues in
2024 were over $2 billion. The company is a constituent of the FTSE 100 Index
(LSE:CTEC). To learn more please visit http://www.convatecgroup.com
(http://www.convatecgroup.com)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RAGPKBBKPBKDAPB